World EPA Congress

Let’s meet in Amsterdam

Join us at the RAI Congress Centre between 2nd-3rd March where we’ll be sharing the latest insights and innovations from the Access Infinity team on industry hot topics.

Join us on Day 1, 12:20 PM to hear:

From data to decisions: a framework for becoming the hero of your market access story

Behind every successful launch is a clear, compelling story and a team equipped to lead it. In this session, David McConkey explores a practical framework that helps Global access leaders decode reimbursement challenges, identify what truly drives performance, and communicate their impact with confidence. Learn how to transform fragmented data into a unified narrative that positions your team as the hero guiding the organisation toward faster access.

David McConkey

Partner – Digital Product Lead

David has approx. 20 years of work experience in the pharmaceutical industry. David has led on HTA negotiations in the UK and Ireland, developed health economic materials, generated launch and pricing strategies for novel drugs, led on cross country affiliate engagement, presented to leadership all the way up to C-Suite and more.

Join us on Day 1, 2:45 PM for our panel discussion:

AI in market access: knowing when it’s the hero (and when it isn’t)

Moderator:  Thomas Gilboy, Product Owner, Access Infinity

Panellists:  

  • Aodan Tynan, Head of Access Implementation, Pricing & Value Demonstration, Astellas

  • Marlene Gyldmark, EU HTA lead, BeOne Medicines

  • Sandeep Kiri, Global Head, Health Economic Evidence, UCB

  • Dilip Patel, SVP Global Pricing and Market Access, Autolus

AI isn’t the only superpower available to market access teams, and sometimes it is not the one you need. In this panel, leaders will discuss how they evaluate problems first, then select the most effective solution, whether that is AI, automation, analytics, process redesign, or human expertise. Lead by Access Infinity’s Product Owner, Tom Gilboy, this session explores common misconceptions about AI’s fit in market access, highlight where alternative tools or approaches outperform AI, and offer practical guidance on building a smarter and more balanced capability set across global and local teams.

Meet Access Infinity's digital team

Keshav Nagaraja

Managing Director

Robert Buckley

Associate Director, Business Development

Russ Leslie

Head of Sales

Louise Bennett

Head of Marketing

 

THOMAS GILBOY​

Product Owner

Louise Bennett

Head of Marketing

 

Ahmed Edathodu

Founding Director

Isabel Rubio

Director

Robert Buckley

Senior Business Development Manager

Thomas Gilboy

Product Owner

Margaret Labban

Product Manager

Best practices in estimating pipeline product prices for early market access teams

It goes without saying that analogues are a great choice for robust evidence because they tell us what’s historically happened to products in similar situations. Of course, there is no perfect analogue that 100% meets your own product, so how do you choose which ones to analyse and review?
There’s much to consider and a lot at stake, not to mention the time pressures you’re facing to answer complex questions, at pace.
So how can early market access professionals take a holistic approach to finding the right analogues in the right time frame?
Our Product Owner Thomas Gilboy explores this at EPA Congress, taking a deeper dive into:
· The analogue analysis challenges faced by today’s early market access teams[LB1]
· How to produce more accurate analysis and evidence to support a product’s launch strategy
· How to pick up the pace of analogue analysis [LB2] so that you can respond rapidly and accurately to enquiries from the [launch?] team

Let’s meet in person

The World EPA Congress 2022 is a great opportunity to share ideas. Block some time for a product demo or chat with our P&MA experts. We look forward to seeing you in Amsterdam.

Meet us at Booth 20.

About Access Infinity

Access Infinity is the world leader of digital transformation in the Pharma Industry. We are a trusted provider of digital platforms and consulting services to leading pharma companies

We come in two flavours

Consulting

The critical support you need to develop a successful value assessment and launch strategy.

Digital products

Time-saving digital solutions that help you launch your brand to the right patients, at the right price, at the right time.

We look forward to meeting you

World EPA Congress is a great opportunity to share ideas. Block some time for a product demo or chat with our P&MA experts. We look forward to seeing you in Amsterdam.